VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,123,500 | -81.8% | 70,000 | -91.2% | 0.16% | -82.4% |
| Q1 2023 | $6,169,200 | -52.1% | 795,000 | +19.5% | 0.89% | -55.7% |
| Q4 2022 | $12,870,769 | +13.3% | 665,156 | +24.7% | 2.00% | +2.2% |
| Q3 2022 | $11,364,000 | +45.2% | 533,264 | -7.3% | 1.96% | -6.1% |
| Q2 2022 | $7,826,000 | -42.1% | 575,000 | 0.0% | 2.09% | -28.5% |
| Q1 2022 | $13,507,000 | -24.7% | 575,000 | -14.3% | 2.92% | -16.3% |
| Q4 2021 | $17,928,000 | +48.4% | 670,940 | -3.6% | 3.49% | +17.3% |
| Q3 2021 | $12,078,000 | -19.5% | 696,126 | -38.5% | 2.97% | -4.3% |
| Q2 2021 | $15,008,000 | – | 1,132,671 | – | 3.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |